logo
Global Health Setbacks Expose Deep Fault Lines as 2030 Targets Loom

Global Health Setbacks Expose Deep Fault Lines as 2030 Targets Loom

Entrepreneur16-05-2025

WHO's Fourteenth General Programme of Work (2025–2028) aims to recalibrate global health ambitions---the new targets include keeping 6 billion people healthier, expanding affordable care access to 5 billion, and better protecting 7 billion from health emergencies
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
As the world enters the final stretch toward the 2030 deadline for achieving health-related Sustainable Development Goals (SDGs), a sobering new report by the World Health Organization (WHO) paints a picture of hard-won progress at risk of being undone. According to the World Health Statistics 2025 report, the COVID-19 pandemic has erased over a decade's worth of health gains, widened inequalities, and left critical global targets out of reach.
Between 2000 and 2019, global healthy life expectancy (HALE) rose from 58.1 to 63.5 years—largely due to reductions in deaths from infectious diseases and childhood illnesses. But the pandemic triggered a sharp 1.6-year drop in HALE within just two years, with adults aged 30 and above bearing the brunt. COVID-related deaths, along with a rise in mental health disorders like depression and anxiety, significantly contributed to this decline.
"The pandemic didn't just disrupt health systems, it reversed decades of progress," said Dr Tedros Adhanom Ghebreyesus, WHO's Director-General. He adds, "Stronger data systems and more equitable health delivery are no longer optional, they are essential."
Missed milestones and stalled momentum
The report underscores that most countries are not on track to meet targets such as reducing premature deaths from noncommunicable diseases (NCDs), lowering maternal and child mortality, and tackling environmental health risks. While there have been modest declines in global mortality from conditions like stroke, heart disease, and respiratory infections, these are being offset by demographic pressures and growing disease burdens in vulnerable populations.
The slowdown is particularly stark when viewed against past momentum. For instance, while maternal mortality fell by one-third and child deaths halved between 2000 and 2019, progress has since stalled. Meanwhile, the global burden of diseases linked to air pollution, unsafe water, poor nutrition, and alcohol consumption remains alarmingly high.
Universal health coverage: still a distant goal
Progress on universal health coverage (UHC)—one of WHO's "Triple Billion" goals remains sluggish. As of 2024, only 431 million more people have gained access to essential health services without financial hardship since 2018, far short of the one-billion target. Moreover, 13.5 per cent of the global population still spends more than 10 per cent of their household income on health-related out-of-pocket expenses.
The report estimates that 344 million people were pushed further into extreme poverty in 2019 due to healthcare costs, a stark reminder of how fragile financial protection remains in many parts of the world.
Workforce woes and immunisation gaps
The global shortage of healthcare workers remains another bottleneck. Although the shortfall decreased from 15.4 million in 2020 to 14.7 million in 2023, projections suggest a gap of 11.1 million will persist by 2030, with nearly 70 per cent of it concentrated in Africa and the Eastern Mediterranean.
Childhood immunisation coverage has improved overall, yet disparities persist especially among populations living in remote areas, urban slums, or conflict zones. Encouragingly, economic-related inequality in vaccine access has narrowed in low-income countries, with DTP3 coverage gaps reducing by more than half in the last decade.
Ambitious, but necessary
In response to the slow pace of progress, WHO's Fourteenth General Programme of Work (2025–2028) aims to recalibrate global health ambitions. The new targets include keeping 6 billion people healthier, expanding affordable care access to 5 billion, and better protecting 7 billion from health emergencies.
"Behind every data point is a person, a child who didn't reach their fifth birthday, a mother lost in childbirth, a life cut short by a preventable disease," said Adhanom Ghebreyesus.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP
Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP

Yahoo

time34 minutes ago

  • Yahoo

Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP

On June 4, 2025, Edelson Lechtzin LLP announced that it has initiated an inquiry into whether the healthcare technology company, Semler Scientific, Inc. (NASDAQ:SMLR), misled investors about its business operations regarding claims tied to its QuantaFlo diagnostic device. A doctor in focus surrounded by colleagues in a hospital setting. In an annual report filed by Semler Scientific, Inc. (NASDAQ:SMLR) on February 28, 2025, the company disclosed that the U.S. Department of Justice (DOJ) was evaluating a potential False Claims Act case. The report triggered immediate market reaction, with the company's shares plummeting by 9.4% to close at $38.89 on March 3. Initiating the inquiry, Edelson Lechtzin LLP has asked for the public and stakeholders' help. Edelson urges those with non-public information regarding Semler Scientific, Inc. (NASDAQ:SMLR) to come forward and assist them in the investigation. It also encourages the company's investors who have suffered losses to follow the inquiry to learn more. The investor confidence has been significantly fluctuating since the disclosure. The stock's performance, which gained 6.49% last month, declined by 13.46% last week. The California-based company, Semler Scientific, Inc. (NASDAQ:SMLR), is known for developing non-invasive medical tools, with QuantaFlo being its most prominent product. Focusing on early disease detection and chronic condition management, the company has positioned itself between healthcare and technology. While we acknowledge the potential of SMLR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Sign in to access your portfolio

Mom, 24, Alleges Docs Refused to Test Her Tumor: 'They Didn't Think Somebody My Age Would Have Pancreatic Cancer'
Mom, 24, Alleges Docs Refused to Test Her Tumor: 'They Didn't Think Somebody My Age Would Have Pancreatic Cancer'

Yahoo

time2 hours ago

  • Yahoo

Mom, 24, Alleges Docs Refused to Test Her Tumor: 'They Didn't Think Somebody My Age Would Have Pancreatic Cancer'

Kanisha Collins, 24, alleges her doctors didn't test a mass on her pancreas, telling her she was too young for pancreatic cancer The mom of a toddler was in the midst of planning her wedding when she was told that she had stage four pancreatic cancer that was "incurable" PEOPLE has reached out to Chesterfield Royal Hospital and Weston Park Hospital for commentA mom who alleges she was told she's too young for pancreatic cancer has been given a bleak, "incurable" diagnosis — and now she's trying to make memories with her toddler and husband before she dies. Kanisha Collins, 24, sought care at the UK's Chesterfield Royal Hospital in December, she told Daily Mail in an article published on Thursday, June 5. her medical team was communicating with cancer specialists at Weston Park Hospital, and the consensus was that she had pancreatitis — an inflammation of the pancreas that can cause nausea, vomiting, and stomach pain. PEOPLE has reached out to Chesterfield Royal Hospital and Weston Park Hospital for comment. A representative for the hospital told The Daily Mail that internal reviews are "already underway." Kanisha told the outlet that this past February, May 30, a scan showed a mass on her pancreas and a blood clot, but her medical team still said she had pancreatitis. 'They wouldn't test the mass on my pancreas, because they didn't think somebody my age would have pancreatic cancer,' Kanisha alleged, claiming she was told the mass was 'benign.' But as she explains, the pain got worse — and she was rushed back to the hospital for more tests; On May 19, she was given the heartbreaking news that she had stage four pancreatic cancer that had spread to her liver and was 'incurable.' Pancreatic cancer is one of the most devastating cancers because it usually doesn't exhibit symptoms until it's too far advanced for effective treatment. As Pancreatic Cancer Action Network explains, even when it's discovered only in the pancreas, the five-year survival rate is 44%. For all types of pancreatic cancer, including if it has spread, the five-year survival rate is 13%. 'I felt discriminated against because I was so young,' Kanisha told the outlet. She'd been in the midst of planning her wedding and celebrating her daughter Amaya's second birthday, but now she says "I feel heartbroken.' 'I have a 2-year-old daughter at home," she said. "I get married on Saturday and I had all that to look forward to in the future.' Her father, Dean, has started a GoFundMe to support Amaya in the future and help Kanisha and her husband Mason build memories — all while paying for cancer treatment. 'I'm on chemo. I'm tired, so it's hard, but I suppose I've got to look for the positive side, that the chemo will shrink enough to give me many years down the line,' she said. 'We're all staying positive about it and hoping that treatment will shrink my tumors enough to give me a few years.' But as Dean bleakly wrote in the GoFundMe, "Amaya will grow up without her mummy by her side through her childhood, teenage years, and adult life. The pain of this loss is unimaginable for our family." As Dean told Daily Mail, 'My aim now is to bring further awareness out there, with regards to cancer, because there's loads of people out there who have experienced it … people just don't seem to be wanting to to push it further forward, to do further tests, purely because she was young.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Read the original article on People

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store